Cardiovascular safety of 5HT1B/1D agonists -: Is there a cause for concern?

被引：48

作者：

Dahlof, CGH ^{[1
]}

Mathew, N

机构：

[1] Sociala Huset Uppg D, Gothenburg Migraine Clin, S-41117 Gothenburg, Sweden

[2] Houston Headache Clin, Houston, TX USA

来源：

CEPHALALGIA | 1998年 / 18卷 / 08期

关键词：

D O I：

10.1046/j.1468-2982.1998.1808539.x

中图分类号：

R74 [神经病学与精神病学];

学科分类号：

摘要：

引用

页码：539 / 545

页数：7

共 72 条

[21]

DAVIES HA, 1985, LANCET, V1, P1011

[22] SUMATRIPTAN - A REVIEW OF ITS PHARMACODYNAMIC AND PHARMACOKINETIC PROPERTIES, AND THERAPEUTIC EFFICACY IN THE ACUTE TREATMENT OF MIGRAINE AND CLUSTER HEADACHE [J].

DECHANT, KL ;

CLISSOLD, SP .

DRUGS, 1992, 43 (05) :776-798

[23]

DEJONG EG, 1992, NED TIJDSCHR GENEES, V136, P2124

[24] Tolerability profile of zolmitriptan (Zomig(TM); 311C90), a novel dual central and peripherally acting 5HT(1B/1D) agonist. International clinical experience based on >3000 subjects treated with zolmitriptan [J].

Edmeads, JG ;

Millson, DS .

CEPHALALGIA, 1997, 17 :41-52

[25] 311C90: Increasing the options for therapy with effective acute antimigraine 5HT(1B/1D) receptor agonists [J].

Ferrari, MD .

NEUROLOGY, 1997, 48 (03) :S21-S24

[26] THE CLINICAL-PHARMACOLOGY, PHARMACOKINETICS AND METABOLISM OF SUMATRIPTAN [J].

FOWLER, PA ;

LACEY, LF ;

THOMAS, M ;

KEENE, ON ;

TANNER, RJN ;

BABER, NS .

EUROPEAN NEUROLOGY, 1991, 31 (05) :291-294

[27]

Galmiche JP, 1995, EUR J GASTROEN HEPAT, V7, P1152

[28] Sumatriptan nasal spray (20 mg/dose) in the acute treatment of cluster headache [J].

Hardebo, JE ;

Dahlof, C .

CEPHALALGIA, 1998, 18 (07) :487-489

[29]

HILLIS WS, 1993, LANCET, V342, P683

[30] SUMATRIPTAN-INDUCED CHEST PAIN [J].

HOOD, S ;

BIRNIE, D ;

MACINTYRE, PD ;

HILLIS, WS .

LANCET, 1994, 344 (8935) :1500-1501

← 1 2 3 4 5 6 7 8 →